Cardiovascular Engineering
Hoda Hatoum, PhD (she/her/hers)
Assistant Professor
Michigan Technological University, Michigan, United States
Sung Jin Park, PhD (he/him/his)
Assistant Professor
Georgia Tech and Emory Univ
Atlanta, Georgia, United States
Feng Zhao, PhD (she/her/hers)
Professor of Biomedical Engineering
Texas A & M University, United States
Esak Lee, PhD (he/him/his)
Assistant Professor
Cornell University
Ithaca, New York, United States
Invited Speaker: Julie Phillippi, PhD (she/her/hers) – University of Pittsburgh
Presenting Author: Alex Khang, PhD (he/him/his) – University of Colorado Boulder
Co-Author: Abigail Barmore – University of Colorado Boulder
Co-Author: Nicole E. Friend, PhD (she/her/hers) – University of Colorado Boulder
Co-Author: Gabriel Wu – University of Colorado Boulder
Last Author: Kristi S. Anseth – University of Colorado Boulder
Presenting Author: Ana Maria Porras, PhD – University of Florida
Co-Author: Samanvitha Deepthi Sudi (she/her/hers) – University of Florida
Co-Author: Tanmayee Kolli (she/her/hers) – University of Florida
Presenting Author: Natalie Simonian, MSE – University of Texas at Austin
Co-Author: Sneha Vakamudi, MD – Ascension Texas Cardiovascular
Co-Author: Mark Pirwitz – Ascension Texas Cardiovascular
Last Author: Michael S. Sacks, PhD (he/him/his) – University of Texas at Austin
Presenting Author: Tina E. Thomas, MSE – University of Pennsylvania
Co-Author: Stanley Stachelek, PhD – Children's Hospital of Philadelphia/ University of PennsylvaniaDr. Stachelek's laboratory focuses largely on the anti-inflammatory properties of the transmembrane protein CD47, and its cognate receptor Signal Regulatory Protein alpha (SIRPa). SIRPa is a Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) expressing protein. ITIMs are a family of protein receptors that function to limit or terminate an immune response. The ultimate goal of Dr. Stachelek's research is to target these receptors to reduce the host inflammatory response that is observed to reduce the efficacy of such cardiovascular devices as stents, bioprosthetic heart valves, and pacemakers.
Primary Investigator: Robert Levy, MD – Children's Hospital of Philadelphia/ University of Pennsylvania